We compared the efficacy and side-effects of continuous infusion versus repeated injections of epMural bupivacaine
comparable in the two groups. Assays showed no difference in bupivacaine blood concentrations between the two groups nor signs of drug accumulation. The constant infusion technique is advantageous since it provides a more regular degree of analgesia with lower doses than those required for patients having repeated injections.
Epidural obstetric analgesia requires repeated injections of local anaesthetics even when a long-acting agent such as bupivacaine is used. Addition of fentanyl to the local anaesthetic increaSes the duration of analgesia; however it does not eliminate the need for reinjections) Since scheduling of reinjections is a function of recurrence of pain, a sufficient level of analgesia cannot be continuously maintained. Numerous studies have shown the efficacy of continuous infusions for obstetrical analgesia. 2,3 Along with development of a stable degree of analgesia, the reports stress the limited degree of hypotension and decreased risk of technical accidents (intrathecal or intravascular injection, contamination during manipulations).
Since both bupivacaine and fentanyl cross the placental barrier it is important to determine blood levels of these two agents. Glover, a Evans and Carrie, 5 Matouskova and Hanson, 6 gosenblatt et al. ,7 for bnpivacaine, and Cousin et al. s for fentanyl, showed that blood levels were far below the threshold values considered to be toxic. Nevertheless, in a recent editorial, Morison and Smedstad 9 noted that for comparison of the two techniques, it was necessary to present series carded out under comparable conditions. For example, in the study by Nadeau and Elliott t~ dosages were very different with the two administration methods, possibly explaining the better results with the continuous infusion.
The purpose of this study is to compare the quality of analgesia, maternal side-effects, effects on the neonate, and maternal blood levels with repeated injections or continuous infusion of bupivacaine and fentanyl. No sensation of discomfort
Methods
After having given informed consent, ~ parturients were assigned to two groups of 22 via a random number draw. Group I was given repeated injections and Group II continuous infusion of the epidural analgesic mixture. Epidural analgesia was required for patient comfort during labour because of dystocia for trial labour.
Maternal characteristics recorded included age, height, weight and parity. After about 100 ml of lactaled Ringer's solution was infused, a lumbar epidural blockade was performed with the patient in the sitting position, once the patient was in active labour and the cemx was 3.5 to 4 cm dilated. Injections were made through a catheter threaded via the L2-Ls interspace. The patient then assumed the supine position, without a tilted position as a role, to assure the homogeneous spread of local anaesthetic solution. If a sensory level of T l~ was not achieved, the patient was tilted head down. After full dilatation, the patient was placed in a semirecumbent position. The mixture included 20 ml of 0.25 per cent plain bupivacaine and 2 ml fentanyt (100 I~g). Following a test dose of 2 ml, parlurients in Group I received a dose of the analgesic mixture determined as a function of their height: 8 ml between 150 and 160 cm and 10 ml for those taller than 160 cm. A dose identical to the initial one was reinjected upon recurrence of pain. Administration was stopped after full dilatation. In Group II, after injection of a 2 ml test dose, patients received a bolus injection half that administered to the preceding group (i.e., 4 or 5 ml). An infusion of the same mixture was started immediately thereafter at a constant flow rate (3 ml.h-t), previously shown to produce satisfactory analgesia. Administration of the mixture was stopped upon full dilatation.
Quality of analgesia was evaluated, using r.he rating scale proposed by Cathelin (Table I ) with a score of 0 equal to complete analgesia (100 per cent) and 5 reproseating no analgesia (0 per cent). Duration of labour was measured between the beginning of the epidutal injection and either full dilatation or decision to carry out a Caesarean section. The frequency of uterine contractions was determined in both groups from three measures performed in each parturient. The amount of oxytocin required was evaluated by determining the number of drops.min-i required for an infusion solution containing 10 p~ syntocinon in 500 ml five per cent glucose. The number of forceps extractions and Caesarean sections was noted.
Blood pressure, heart rate and respiratory rate were measured at 5 and then 15 min intervals. Adverse effects, including vomiting, dizziness, pruritus and respiratory depression (a rate less than 10/rain) were documented. After delivery, the condition of the newborn was assessed at 1 and 5 rain, using Apgar scores, and at 30 rain using a neuro-sensorial evaluation reported by AmieI-Tison. t t Total dosages of bupivacaine and fentanyl used in the two groups were calculated. Venous blood samples were taken from 15 parturients of each group for assay of bupivacalne and fentanyl. In Group I, samples were taken 20, ~,0 and 60 minutes after each injection and upon complete dilation. In Group II, they were taken 20, 40, 60, 120 and 180 minutes following the initial bolus, and again upon complete dilation.
Bupivacaine was assayed by a high-pressure liquid chromatography assay with a threshold of 0.10 p.g.ml-t. Fentanyl was assayed by radioimmunoassay with a Fen. RIA.200 kit supplied by the Belgium National Institute (acceptable precision for levels above 0.1 ng-ml-t), providing a detection threshold of 0.02 ng.ml-J plasma. Statistical analysis was carried out using Student's t test for small groups and by analysis of variance. Dunnett's test lz was used to assess the Apgar scores.
Results
The two groups were similar in terms of age (24.77 ~ 0.92 years for Group I, 26.82 -+ 1.22 years for group H), height (160.77 • 1.08 and 161.23 ---1.11 cm), weight (66.68 _+ 2.63 and 69.95 ---2.25 kg) and panty (1.14 + 0.75 and 1.14 -+ 0.99). Epidural anaesthesia was begun at the same degree of dilatation in the two groups (respectively 3.88 • 0.18 em and 3.77 + O21 cm).
Analgesia developed more rapidly in Group I (7.30 ---0.30 minutes) than in Group II (12.57 -0.32 minutes) (p < 0.001). Development of analgesia is given in the Figure. In both groups analgesia was excellent, without significant differences at T = 15, T = 30 and T = 60. A diffe~nce between the two groups appeared a! T = 90 and became highly significant (p < 0.001) at T = 180. Analgesia was better and more constant in Group II than in Group I. In Group I, analgesia upon full dilatation was rated 3.06 -O. 82 after the t"trst injection (delivery of less than 90 minutes duration) and 2.60 ~ 0.41 after one reinjection (delivery in between 90 to 180 minutes). In Group ii, analgesia was rated 1.85 -+ 0.37 for short labour (4 hours) and 1.77 ---0.26 for longer labour. The difference between analgesia scores with the two techniques was significant (p < 0.05) for short labor and highly significant (p < 0.001) for longer labor.
There were no significant differences in terms of the course of delivery in the two groups. The mean intervals between two contractions were respectively 175 -+ 2.29 seconds and 175 • 2.25 seconds, and the rate of infusion of syntocinon was respectively 15 • 0.3 and 15 • 0.23 drops.min -l . Duration of labour was 139.0 ~ 63.50 minutes in group I and 133.63 • 54.55 minutes in group II. The frequency of forceps extractions was the same in the two groups: forceps were required for three patients in group I and four in group II, Caesarean sections for six in group I and five in group IL The high frequency of forceps and Caesarean sections can be explained by indications of peridnral analgesia: only anticipated difficult labour. Blood pressure, heart rate and respiratory rate show no significant differences. No side effects occurred. Consumption of the analgesic mixture was calculated as a fur~ction of duration of epidural analgesia: 7.70 +--1.35 ml.h-1 in Group I and 5.32 +-0.95 ml.h-I in Group II. It was significantly shorter in group II than in group I (p < 0.001). There were no significant differences between the two groups in terms of the Apgar scores (Table H) orofthe Amiel test (27 _-L-0.33 and 27 + 0.36, respectively for a total score of 30).
Results of assays are shown in Tables HI and IV . Assays for bupivacaine and fentanyl during continuous infusion (20, 40 , 60, 120 and 180 minutes after the bolus) did not show any significant differences. Upon complete dilatation, in Group I the mean bupivacaine blood concenlration was 0.238 -0.049 btg.m1-1, versus 0.245 -+ 0.049 ~g.ml -t in Group II; the difference between the two groups was not significant. The mean blood feutanyl concentration was 0.278 -+ 0.42 ng.ml-~ in Group I and 0.258 -+ 0.038 ng.m1-1 in Group II. The difference between the two groups was also not significant.
Discussion
Time to onset of analgesia is shortened when fentanyl is combined with bupivacaine, t J3 possibly due to rapid uptake of the morphine derivative into the blood 14 and also as fentanyl penetrates into the substantia gelatinosa better than either meperidine or morphine. Is In the present study, time to onset of analgesia in Group I was similar to that recorded by other authors: between five and ten minutes. The longer latency in Group II can be explained by the fact that the volume of the initial bolus was smaller than that administered to Group I, or in other studies. The delay was moderate (approximately five minutes) and cannot be considered to be a major drawback. In spite of the absence of a double blind design, after the first ten minutes quality of analgesia was better in Group ]i than in Group I. With the repeated injection technique, it would seem better to give repeat doses prior to the recurrence of pain, resulting in more steady analgesia, and avoidance of tachyphylaxis. ~6 But because of the unexpected duration of action of the precedent injection, it cmfld procure too frequent injections and excessively high plasma concentrations.
Evans and Carrie 5 undertook a prospective comparison of repeated injections versus continuous infusion for epidural anaesthesia with bupivaeaine alone. They reported that quality of analgesia was clearly superior with the The present study suggests the advantage of continuous infusion. Indeed, there was some significant difference in favour of Group II in terms of dosage of the analgesic mixture (5.32 • 0.95 versus 7.70 -1.35 ml.h-t). The course of labour was comparable (same interval between two contractions, same duration of delivery), and the number of forceps extractions and Caesarean sections was similar. There were no differences in dosage between the two groups. The assays of bupivacaine and fentanyl blood levels showed no significant difference between the two groups at any time. Nevertheless, it is interesting to note that, administered by continuous infusion, the dose selected was sufficient to provide satisfactory analgesia, did not cause drug-accumulation phenomena, and yielded blood coneentrafions identical to those for the first group at the end of the second stage of labour. None of the authors who assayed bupivacaine blood levels dunng continuous rate infusions for this indication 4"7'a9 have reported drug accumulation or tachyphylaxis. Since the majority of published studies concern either comparisons between bupivacaine and bupivacaine-fentanyl administered discontinuously ~7-19 or injection of bupivacaine alone at a constant ratc 2'4'5'7'2~ it is difficult to compare the closes chosen for this study with those reported.
By comparison with 0.25 per cent bupivacaine administered alone by continuous infusion, fentanyl allows a major decrease in dosage. When using bupivacaine alone, Rosenblatt etal. 7 gave an initial bolus of 10 ml followed by 10 ml'h-t. Evans and Carrie 5 employed an initial bolus of 7-10 ml followed by 9.48 ml.h -t and Glover 4 used a 10-ml bolus followed by 6-8 m]'h -t . Matouskova etal. 23 reduced the initial dose to 7 ml, followed by onty 5 ml.h -t. However, a supplementary injection was sometimes required during the course of labour, and delivery required supplementary analgesia by local infiltration or pudendal nerve block. Comparable results were reported by Taylor 24 with 6 ml-h-i of 0.25 per cent bupivacaine. In the present study, no further injections were required to maintain high-quality analgesia, until the end of delivery.
Bupivacaine and fentanyl levels in maternal blood were always far below those considered to be potentially dangerous: 1.6 tzg'ml-i bupivacaine in obstetrics accordlag to Reynolds and Taylor (25) and 1-2 ng.ml-t fantanyl according to Hug and Murphy 26 in a study performed in rats. As seen in Table IV , plasma concentrations of bupivacaine peaked 20 rain after injection, but fentanyl did not show the same increase. This effect can be explained by differences in pharmaeokinetics. The initial volume of distribution is larger for fentanyl than for bupivaeaine. While transplacental passage of these two drugs is rapid, the maternal blood levels achieved were not dangerous, in view of published data. 
